WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 10 fonti

White House Denies Trump Got Unapproved Obesity Drug

Compassionate use of retatrutide granted for someone with sleep apnea, pulmonary hypertension

Raccontata danewrepublic.comforbes.commedpagetoday.comhuffpost.comgizmodo.comindependent.co.uknymag.comwashingtonexaminer.combenzinga.comhindustantimes.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
medpagetoday.comStai leggendo2 g fa

White House Denies Trump Got Unapproved Obesity Drug

Compassionate use of retatrutide granted for someone with sleep apnea, pulmonary hypertension

originale
benzinga.com1 g fa

White House Denies Report Linking Trump To Eli Lilly's Experimental Obesity Treatment: 'Not For The Presi

White House denies reports Trump received Eli Lilly's unapproved obesity drug retatrutide through an FDA program.

Leggi questa versione → originale
washingtonexaminer.com1 g fa

White House denies report Trump got access to experimental weight loss drug

The White House denied that the single approval of Eli Lilly's highly-anticipated weight loss drug retatrutide was for Trump after a STAT report.

Leggi questa versione → originale
independent.co.uk1 g fa

White House denies Trump was mystery patient given early access to weight-loss drug

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWhite House officials are denying that President Donald Trump was the 79-year-old…

Leggi questa versione → originale
newrepublic.com2 g fa

White House Flips Out Over Report Trump May Be on Weight Loss Drug

A stunning report reveals the president may have gotten an early access to an obesity drug to treat major medical issues.

Leggi questa versione → originale
forbes.com2 g fa

White House Denies Trump Was Given Exclusive Weight Loss Drug

A report from STAT News said Eli Lilly and the FDA gave a 79-year-old man exclusive access to the drug after a request for it was made in April.

Leggi questa versione → originale

Timeline cronologica

  1. martedì 23 giugno 2026·newrepublic.com

    Remember That Time Trump Said He “Probably Should” Take Ozempic?

    A bombshell report about how a 79-year-old man got early access to a weight loss drug has all eyes on the president.

  2. martedì 23 giugno 2026·newrepublic.com

    White House Flips Out Over Report Trump May Be on Weight Loss Drug

    A stunning report reveals the president may have gotten an early access to an obesity drug to treat major medical issues.

  3. martedì 23 giugno 2026·newrepublic.com

    Eli Lilly Approved Obesity Drug for Mystery 79-Year-Old Patient

    Questions are swirling over Donald Trump’s health after a bombshell report revealed a mystery man was getting unprecedented access to a weight-loss drug.

  4. martedì 23 giugno 2026·forbes.com

    White House Denies Trump Was Given Exclusive Weight Loss Drug

    A report from STAT News said Eli Lilly and the FDA gave a 79-year-old man exclusive access to the drug after a request for it was made in April.

  5. martedì 23 giugno 2026·medpagetoday.com

    White House Denies Trump Got Unapproved Obesity Drug

    Compassionate use of retatrutide granted for someone with sleep apnea, pulmonary hypertension

  6. martedì 23 giugno 2026·huffpost.com

    It Kinda Looks Like Trump Might Be Taking An Experimental Obesity Drug?

    Retatrutide has not been approved by the FDA, but precisely one 79-year-old man was granted access via "compassionate use."

  7. martedì 23 giugno 2026·gizmodo.com

    Just Who Is the Mystery 79-Year-Old Patient Who Got Special Access to an Experimental Weight Loss Drug?

    The White House has denied that the application was filed on behalf of President Donald Trump.

  8. martedì 23 giugno 2026·independent.co.uk

    White House denies Trump is the mystery patient who got early access to obesity drug

    A White House spokesman said theories that President Trump sought the drug were ‘baseless speculation’

  9. martedì 23 giugno 2026·nymag.com

    Did Trump Get Early Access to Eli Lilly’s New Weight-Loss Drug?

    The FDA let one 79-year-old take an experimental obesity drug. That sure sounds like the president, but let’s examine the evidence.

  10. mercoledì 24 giugno 2026·independent.co.uk

    White House denies Trump was mystery patient given early access to weight-loss drug

    Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWhite House officials are denying that…

  11. mercoledì 24 giugno 2026·washingtonexaminer.com

    White House denies report Trump got access to experimental weight loss drug

    The White House denied that the single approval of Eli Lilly's highly-anticipated weight loss drug retatrutide was for Trump after a STAT report.

  12. mercoledì 24 giugno 2026·benzinga.com

    White House Denies Report Linking Trump To Eli Lilly's Experimental Obesity Treatment: 'Not For The Presi

    White House denies reports Trump received Eli Lilly's unapproved obesity drug retatrutide through an FDA program.

  13. giovedì 25 giugno 2026·hindustantimes.com

    Is Trump getting Eli Lilly's retatrutide? ‘Breathless’ clip viral amid debunked ‘compassionate use’ rumor

    Trump faced fresh health speculation after reports linked him to an experimental drug and a viral video, but the White House denied the medication claim.